4/23/2024

Janusmed fosterpåverkan

Janusmed fosterpåverkan – Logimax

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Metoprolol

Metoprolol

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. United Kingdom Teratology Information Services (UKTIS). Beta-blockers in pregnancy. 2016. Tillgänglig från: www.toxbase.com. Hämtad 2017-11-07.

  2. Yakoob MY, Bateman BT, Ho E, Hernandez-Diaz S, Franklin JM, Goodman JE et al. The risk of congenital malformations associated with exposure to β-blockers early in pregnancy: a meta-analysis. Hypertension. 2013;62:375-81.

  3. Lennestål R, Otterblad Olausson P, Källén B. Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants. Eur J Clin Pharmacol 2009;65:615-25.

  4. Briggs G, Freeman RK, Towers CV, Forinash AB. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 11th ed; 2017.

  5. UKTIS. Metoprolol in pregnancy 2016 . UKTIS [www]. UKTIS. [updated 2016-03-01, cited 2020-04-14].

  1. United Kingdom Teratology Information Services (UKTIS). Beta-blockers in pregnancy. 2016. Tillgänglig från: www.toxbase.com. Hämtad 2017-11-07.
  2. Yakoob MY, Bateman BT, Ho E, Hernandez-Diaz S, Franklin JM, Goodman JE et al. The risk of congenital malformations associated with exposure to β-blockers early in pregnancy: a meta-analysis. Hypertension. 2013;62:375-81.
  3. Lennestål R, Otterblad Olausson P, Källén B. Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants. Eur J Clin Pharmacol 2009;65:615-25.
  4. Briggs G, Freeman RK, Towers CV, Forinash AB. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 11th ed; 2017.
  5. UKTIS. Metoprolol in pregnancy 2016 . UKTIS [www]. UKTIS. [updated 2016-03-01, cited 2020-04-14].
2 2
2 2

Felodipin

Felodipin

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Briggs G, Freeman RK, Towers CV, Forinash AB. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 11th ed; 2017.

  2. UKTIS. Calcium Channel Blockers in pregnancy. 2016. Available from: https://toxbase.org. [updated 2016-07-01, cited 2020-04-06].

  3. Weber-Schoendorfer C, Hannemann D, Meister R, Eléfant E, Cuppers-Maarschalkerweerd B, Arnon J et al. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study. Reprod Toxicol. 2008;26(1):24-30.

  4. Magee LA, Schick B, Donnenfeld AE et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 1996;174:823-8.

  5. Sorensen HT, Steffensen FH, Olesen C et al. Pregnancy outcome in women exposed to calcium channel blockers. Reprod Toxicol 1998;12:383-4.

  1. Briggs G, Freeman RK, Towers CV, Forinash AB. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 11th ed; 2017.
  2. UKTIS. Calcium Channel Blockers in pregnancy. 2016. Available from: https://toxbase.org. [updated 2016-07-01, cited 2020-04-06].
  3. Weber-Schoendorfer C, Hannemann D, Meister R, Eléfant E, Cuppers-Maarschalkerweerd B, Arnon J et al. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study. Reprod Toxicol. 2008;26(1):24-30.
  4. Magee LA, Schick B, Donnenfeld AE et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 1996;174:823-8.
  5. Sorensen HT, Steffensen FH, Olesen C et al. Pregnancy outcome in women exposed to calcium channel blockers. Reprod Toxicol 1998;12:383-4.